April 24, 2025 April 24, 2025Categories Press ReleasesPress Release: Estimating complex immune cell structures by AI tools for survival prediction in advanced melanoma
April 9, 2024 April 9, 2024Categories Announcements News StoriesThe April 2024 News from ECOG-ACRIN blog is now available
March 7, 2024 March 7, 2024Categories Announcements News StoriesThe March 2024 News from ECOG-ACRIN blog is now available
February 9, 2024 February 9, 2024Categories Announcements News StoriesThe January/February 2024 News from ECOG-ACRIN blog is now available
January 22, 2024 January 22, 2024Categories Announcements News StoriesThe Winter 2024 advocacy blog Considering Clinical Trials is now available
January 17, 2024 January 17, 2024Categories Press ReleasesPress Release: ECOG-ACRIN research team led by Michael Atkins, MD receives Journal of Clinical Oncology 2023 Paper of the Year
May 31, 2023 May 31, 2023Categories AnnouncementsYour daily guide to ASCO 2023 research presentations by ECOG-ACRIN and PrECOG
February 23, 2023 February 23, 2023Categories News StoriesA focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma
October 4, 2022 October 4, 2022Categories News StoriesDREAMseq trial clarifies immunotherapy, targeted treatment order for patients with BRAF-mutant metastatic melanoma
